Article Details
Retrieved on: 2021-04-26 13:32:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drugs under review this week — Merck's Keytruda, Roche's Tecentriq and Bristol Myers Squibb's Opdivo — are part of a recent wave of “ ...
Article found on: wreg.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here